Mounjaro Pictures: What to Expect From the Pen, Injection Sites and Weight Changes

The Mounjaro KwikPen: what you are looking at

The Mounjaro KwikPen is a slim, cylindrical auto-injector roughly the length of a standard pen, with a clear medication window in the middle. Each pen contains four weekly doses, so one pen lasts a month. The needle is concealed inside a grey cap and is short and fine (4–6 mm in most configurations) which is worth knowing if you have been putting off starting because you are picturing something more alarming.

UK strengths run from 2.5 mg up to 15 mg. The starter dose (2.5 mg) is the same pen design as the higher doses; the strength is printed on the label and colour-coded by Eli Lilly. Pens are stored in the fridge at 2–8 °C (the fridge door shelf works fine) but should be allowed to come close to room temperature before you inject. The exact window for room-temperature storage is set out in the Patient Information Leaflet that comes with your pen; always follow that rather than any figure you find online. For a closer look at the molecule behind the medicine, our page on Mounjaro's chemical structure explains what the tirzepatide molecule is and how it differs from other GLP-1 medicines.

If you are comparing pictures of different pens and wondering whether the one in front of you is genuine, the MHRA's Drug Safety Update index carries official guidance on identifying counterfeit weight-loss pens, worth a read before purchasing from any source.

Injection sites: what a correctly prepared site looks like

The three licensed injection sites are the abdomen (at least a few centimetres from the navel), the outer thigh and the upper arm. In pictures, a correctly prepared site looks clean and dry, with no active skin irritation, rash, or bruising from a recent injection in the same spot. Rotating between sites (and moving around within each site each week) is the practical habit that keeps skin healthy over months of treatment.

Immediately after injecting, a small raised area of skin is normal and settles within minutes. Mild redness or slight bruising at the injection site appears in some people and is generally short-lived. These are among the injection-site reactions you will see if you look up mounjaro weight loss pictures taken by people documenting their treatment. If you notice a rash that goes beyond the immediate injection site, our page on Mounjaro rash pictures covers what to look for and when to seek medical advice.

Our broader Mounjaro treatment guide covers injection technique alongside a full overview of the medicine, which is a useful companion if you are still deciding whether to proceed.

Mounjaro weight loss pictures: what they show and what they leave out

Weight-loss progress pictures shared online are usually taken at 12, 24 and 52 weeks into treatment. They tend to show visible changes in the face, abdomen and upper body, which reflects where tirzepatide's appetite-suppressing effect has the most consistent impact over time. The SURMOUNT-1 clinical trial, published in the New England Journal of Medicine, recorded an average body-weight reduction of around 20–21% over 72 weeks at 15 mg, which, for someone weighing 100 kg at the start, would be roughly 20 kg.

What before-and-after photographs cannot capture is the variation between individuals. Starting weight, dose, adherence, diet quality, sleep, activity levels and several biological factors all shape the result. Some people see significant change by week 12; others find the effects build gradually over the full treatment period. Progress photos also cannot tell you whether a given person was on a maintenance dose or still titrating, or whether the image was taken at a moment of reduced food intake. Treat them as illustrations of possibility rather than promises, and be especially cautious about results pictures shared alongside links to purchase the medicine, given the well-documented problem with counterfeit pens sold through social media.

If you are curious about what happens when treatment eventually stops, our page on tapering off Mounjaro covers what the evidence says about weight after discontinuation.

Deciding whether to start: what a picture cannot tell you

Looking at pictures is a starting point, not a finishing one. The decision that actually matters is whether Mounjaro is clinically appropriate for you, which depends on your BMI, medical history, any medicines you are already taking, and a conversation with a prescriber who can read the full picture.

Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not guarantee suitability; the prescriber weighs up the whole clinical picture. You can find a detailed breakdown on our weight-loss treatment overview, and if you want context on private pricing before you commit, our Mounjaro price comparison page sets out what a legitimate UK private prescription typically includes.

If you have questions that go beyond what any picture can answer, speaking to one of our prescribers is straightforward. At nume, a GPhC-registered Independent Prescriber reads every consultation personally. You can start your free consultation and have your answers reviewed the same day.